InsidersTradesSigma
Track the CMG제약 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, CMG제약 has logged 3 insider filings. Market capitalisation: €5.2m. The latest transaction was disclosed on 7 July 2026 (Purchase). Among the most active insiders: CMG제약. The full history is free.
3
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,262 of 29,063 companies
25.1
score / 100
Value9
Quality41
FCF yld-52%
Earn yld-12%
EV/EBITDA·
ROE2.3%
Gross mgn58%
Net mgn-9.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 July 2026
关于 CMG제약
CMG제약 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于药品开发和商业化。